AzTrials
AzTrials

Alveolar Bone AtrophyNCT07162389

Comparative (Short vs. Standard) Length Implants in Early Stability Patterns.

A study testing Shallow-Threaded Short Implant (SHI) and Shallow-Threaded Standard Implant (SDI) in people with Alveolar Bone Atrophy, run by University of Science and Technology, Yemen at 1 site in Yemen.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Early Stability of Short vs. Standard Dental Implants in the Posterior Mandible This study compares how well short dental implants (7mm) work compared to standard-length implants (11mm) when placed in the back part of the lower jaw. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Alveolar Bone Atrophy
What is being tested?
Shallow-Threaded Short Implant (SHI) and Shallow-Threaded Standard Implant (SDI)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteYemen
Study dates
1 Aug 2025to 1 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 1. Adults ≥18 years with partial posterior mandibular edentulism. 2. Bone height ≥7 mm and width >6 mm (CBCT-confirmed). 3. D2/D3 bone density (HU: 350-1250). 4. Healed posterior mandibular sites (3-6 months post-extraction). 5. Good oral hygiene (plaque index ≤1). 6. Willingness to adhere to study protocols.

Who cannot join

  • 1. Uncontrolled systemic diseases (e.g., diabetes with HbA1c >7%, liver disease) or medications affecting bone healing (e.g., corticosteroids, bisphosphonates).
  • 2. History of head/neck radiotherapy (with in past year). 3. Heavy smoking (>10 cigarettes/day). 4. Absolute contraindications for oral surgery (e.g., recent MI/CVA < 6months, bleeding disorders).
  • 5. Active periodontal disease, parafunctional habits as bruxism, or prior bone grafting at the site.

Trial locations and contacts

1 site in 1 country.

Yemen1 site
  • university of Sciences and Technology

    Sanaa, 009671

Other trials in Yemen

About this study

Official title: Early Stability of Short Dental Implants With Shallow Threads in the Posterior Mandible: A Controlled Clinical Pilot Study .

Early Stability of Short vs. Standard Dental Implants in the Posterior Mandible

This study compares how well short dental implants (7mm) work compared to standard-length implants (11mm) when placed in the back part of the lower jaw. Both types of implants have special shallow threads designed to reduce stress on the bone. The main goal is to see how stable they are during the first 4 weeks after placement-a critical time for healing.

Read more
  • Short implants may be a good option for patients with limited jawbone height, avoiding the need for bone grafting.
  • Understanding their early stability helps dentists decide when it's safe to place teeth on them.
  • This study uses advanced tools like 3D scans (CBCT) and implant stability measurements (ISQ) to track healing.

What will happen in the study?

  1. Screening: A dental exam and 3D scan to check bone quality.
  2. Implant Placement:
  • Short (7mm) or standard (11mm) implant, depending on your bone height.
  • Minimally invasive surgery with local anesthesia.
  1. Follow-ups: Painless stability checks at end of 1, 2, 3, and 4 weeks using a small device (RFA).

Who can participate?

Adults (18-60 years) missing posterior teeth in the lower jaw, with:

  • Enough bone width (≥6.5mm).
  • No uncontrolled health conditions (e.g., severe diabetes).
  • Non-smokers or light smokers (<10 cigarettes/day).
  • Benefits: Free implant placement and monitoring; contributes to better dental care.
  • Risks: Typical surgery risks (swelling, infection); rare nerve injury (<5% chance).

How long is the study?

  • Active participation: 4 weeks (with optional long-term follow-up).
  • Total study duration: ~12 months (including data analysis). Mohammad Abdulwahab Al-Jonaid University of Science and Technology, Sana'a.
  • Supervisor: Dr. Ali Al-Hudaied, Oral and Maxillofacial Surgery Specialist.
Read the detailed description

A prospective, controlled, parallel-group pilot clinical trial comparing 7mm short implants (SHI) versus 11mm standard implants (SDI) with identical shallow-thread macrodesign (depth <0.5mm) and 4.2mm diameter. Implant allocation is anatomically driven based on CBCT-measured vertical bone height (7mm group: 8.5-9mm residual bone; 11mm group: ≥12.5mm).

Technical Innovations

  1. Thread Geometry: Dual shallow-thread reverse-buttress design (0.2-0.5mm depth) with progressive pitch to optimize cortical engagement while minimizing shear stress (Ao et al. 2010).
  2. Surgical Protocol: Standardized osteotomy using under-drilling for D2 bone (final drill diameter reduced by 0.2mm) and non-condensing drilling for D3 bone to prevent over-compression.
  3. Stability Metrics:
  • Primary Stability: ITV (last quarter-turn torque) + ISQ (Penguin RFA, mean of 4-directional measurements).
  • Dynamic Stability: ISQ tracked at T0 (baseline), T1 (7d), T2 (14d), T3 (21d), T4 (28d) to capture dip magnitude (ΔISQ) and recovery onset (start of biological stability).

Bone Density Integration

  • Pre-op CBCT: Hounsfield Unit (HU) stratification (D2: 800-1250 HU; D3: 350-850 HU) with 2mm² ROI analysis at coronal/middle/apical levels.
  • Intra-op Validation: Tactile assessment using Lekholm \& Zarb scale (D2: "white pine" resistance; D3: "balsa wood").

Quality Controls

  • Operator Standardization: Single experienced surgeon performs all placements.
  • RFA Calibration: Pre-measurement checks with reference block and standardized SmartPeg torque (5-10 Ncm).
  • Blinding: ISQ measurements by research assistant masked to implant type.

Rationale for 4-Week Endpoint

Focuses on the critical early healing phase where:

  1. Primary stability (mechanical) transitions to secondary stability (biological).
  2. The "stability dip" (week 2-4) predicts osseointegration failure risk.

Technical Constraints

  • Limited Sample Size (n=20): Pilot study design prioritizes feasibility over powered comparisons.
  • Bone Density Homogeneity: Excludes D1/D4 bone to reduce confounding.

Innovative Aspects

First clinical study to combine:

  1. Shallow threads + short length in posterior mandible.
  2. Weekly RFA tracking during the dip phase.
  3. HU-quantified bone density correlation with ISQ trends.
Being tested
Shallow-Threaded Short Implant (SHI), Shallow-Threaded Standard Implant (SDI)
Keywords
RFA, ISQ, Short dental implants, Shallow-threaded, Posterior Mandible, Early Dynamic Changes, primary Stability, Stability dip
Medical subject headings
Alveolar Bone Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Shallow-Threaded Short Implant (SHI)Device

    A 7mm long, 4.2mm diameter dental implant with shallow thread (<0.5mm depth) Macrodesign, surgically placed in the jawbone to restore missing teeth

  • Shallow-Threaded Standard Implant (SDI)Device

    A 11mm long, 4.2mm diameter dental implant with shallow thread (<0.5mm depth) macrodesign, surgically placed in the jawbone to restore missing teeth.

Study groups in NCT07162389
Study groupRoleWhat they receive
Short Dental Implant Group.ExperimentalGroup A, Shallow-Threaded ,length 7mm, diameter 4.2mm,10 single dental implants.
Receives: Device: Shallow-Threaded Short Implant (SHI); Device: Shallow-Threaded Standard Implant (SDI)
Standard Dental Implant Group.Active comparatorGroup B, Shallow-Threaded ,length 11mm, diameter 4.2mm,10 single dental implants.
Receives: Device: Shallow-Threaded Short Implant (SHI); Device: Shallow-Threaded Standard Implant (SDI)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Implant Stability Quotient (ISQ) at Baseline (T0)

    Mean Resonance frequency Analysis(RFA) measurement taken immediately post-implantation(T0), to assess primary mechanical stability. ISQ range 1-100, low stability <60, medium stability 60 to 69, high more than or equal 70. Reported as mean ISQ value per group.

    Measured: Measurement at implant placement(Day 0)

  2. Insertion Torque value- ITV.

    The rotational torque in Ncm,applied during the final quarter-turn of implant insertion. This is direct measure of primary mechanical stability. Reported as mean ITV per group.

    Measured: Measurement at during implant placement (intraoperative)

  3. Magnitude of Stability Dip

    The mean lowest point of stability curve , calculated as the greatest negative change in ISQ value from the baseline T0, measurement for each implant during the 4 -week monitoring period.

    Measured: from implant placement (Day 0) through week4

  4. Time of Onset of Secondary Stability

    The mean time in days post implantation at which the ISQ value begins to consistently increase, indicating the start biological secondary stability. Defined as the time point after the nadir -T2or T3.where the ISQ value shows a positive increase confirmed at the subsequent measurement.

    Measured: from Day0 , through week 4.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2025
  2. Study start1 Aug 2025
  3. Primary completion1 Feb 2026 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Interventional Study A Prospective, controlled, parallel-group, anatomically allocated pilot study . Anatomically-Driven Allocation * Group A (Short Implants): 7mm implants placed in sites with 8.5-9mm residual bone height (measured from crest to inferior alveolar nerve + 1.5mm safety margin). * Group B (Standard Implants): 11mm implants placed in sites with ≥12.5mm bone height. * Rationale: Mimics real-world clinical decision-making where implant length is determined by available bone anatomy. 2\. Technical Controls: * Standardized diameter: All implants 4.2mm (Tiologic Twinfit system). * Identical surface/macrodesign: SLA surface, shallow threads (\<0.5mm depth), reverse-buttress profile. * Surgical calibration: Single operator, under-drilling protocol for D2 bone (final drill -0.2mm), non-condensing drilling for D3 bone. 3\. Dynamic Monitoring Protocol: * Timepoints: T0 immediate, T1,T2,T3,T4 (at the end of weeks- 1,2,3,4)
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07162389
Sponsor's protocol ID
1447/0062/UREC/UST.
Status last verified
Sep 2025
First submitted
18 Jul 2025
Last updated
9 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Anonymized data available upon request after publication

Questions about this trial

What is this clinical trial studying?

A study testing Shallow-Threaded Short Implant (SHI) and Shallow-Threaded Standard Implant (SDI) in people with Alveolar Bone Atrophy, run by University of Science and Technology, Yemen at 1 site in Yemen.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 9 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Yemen. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Implant Stability Quotient (ISQ) at Baseline (T0) (time frame: Measurement at implant placement(Day 0)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in